Kidney and hypertension: is there a place for renalase?

Edyta Zbroch1, Jolanta Małyszko, Jacek Małyszko

  • 1Department of Nephrology and Transplantology, Medical University of Bialystok, Białystok, Poland. edzbroch@poczta.onet.pl

Insights

Chronic kidney disease (CKD) patients often have hypertension due to increased sympathetic activity. Lower levels of the protein renalase, which degrades catecholamines, may contribute to this condition.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Hypertension is prevalent in Chronic Kidney Disease (CKD), affecting 80-85% of patients.
  • Enhanced sympathetic nervous system activity and reduced catecholamine clearance contribute to elevated blood pressure in CKD.
  • Renalase, a newly discovered protein, degrades catecholamines and may influence hemodynamic function.

Purpose of the Study:

  • To investigate the role of renalase in the pathogenesis of hypertension in Chronic Kidney Disease (CKD).
  • To explore the association between renalase levels and hypertension in CKD patients.

Main Methods:

  • Review of existing literature on renalase, catecholamines, and hypertension in CKD.
  • Analysis of studies reporting serum renalase levels in CKD and hemodialysis patients compared to healthy individuals.

Main Results:

  • Studies indicate lower serum renalase levels in CKD and hemodialysis patients compared to healthy controls.
  • Conflicting reports exist, with some studies showing increased renalase levels in dialysis patients and kidney transplant recipients.
  • Data linking renalase gene expression, activity, and concentration to its function in hypertension is currently lacking.

Conclusions:

  • The precise role of renalase in CKD-associated hypertension requires further investigation.
  • Future studies must establish whether renalase is actively involved in hypertension development or is merely an indicator.
  • Clarifying renalase's function is crucial for understanding and potentially treating hypertension in CKD.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Introduction to Urinary System01:13

Introduction to Urinary System

The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...